23andMe
For adults seeking personal genetic discovery, ancestry mapping, and proactive health management.
23andMe - DNA Testing
Snapshot
Who is 23andMe?
Providing personal genetic insights for ancestry and health management. Helping users navigate their DNA data through actionable reports and clinical tools.
Target audience
Portfolio
Free 1Last updated
23andMe - DNA Testing
v15.20.0
4mo ago
Publisher DNA
What defines 23andMe?
Publisher DNA
Primary focus
Personal genomics and health insights
Scale
indie
Target audience
Adults seeking personal genetic discovery, ancestry mapping, and proactive health management.
Signature Patterns
- •Freemium model with aggressive pay-to-view gating for legacy features
- •Multi-tier subscription strategy ranging from ancestry reports to clinical health services
- •Integration of genetic data with ongoing research and clinical care tools
- •Focus on high-volume data collection to power proprietary health insights
Portfolio momentum
Released 12 updates in the last 6 months for their single active application, indicating a high frequency of maintenance and feature iteration.
Portfolio
What does 23andMe ship?
Apps
1 app analysed
Explore your DNA! Learn about your ancestry, health, traits, and more.
Clinical-grade health reporting differentiates from genealogy-first rivals
- Detailed ancestry and health reports provide high value for personal discovery and familial connection
- Aggressive monetization and pay-to-view gating of previously free features frustrate long-term legacy users
User Sentiment
How do users feel about their apps?
0
Positive apps
1
Neutral / mixed
0
Negative apps
55/100
Avg sentiment score
Rivals
Who does 23andMe compete with?
The rivals identified
Nemeses(1)
Dominates the genealogy-first DNA market with a massive user base and high-velocity feature updates.
Contenders(1)
A strong secondary player in the genealogy space with high release velocity and significant user engagement.
Same space(2)
Operates in the health-testing space, focusing on diagnostic lab results rather than ancestry.
Targets the performance-optimization niche within the broader health and fitness category.
New entrants(1)
An emerging platform with high engagement potential, though currently positioned in the entertainment space.
The Analyst's Read
The bottom line on 23andMe
Bottom line
23andMe holds a strong market position through its extensive genetic database, though its transition to a subscription-heavy model presents a churn risk. The platform's ability to successfully upsell existing users to clinical health services will be the primary indicator of its long-term viability.
Frequently asked questions
How many apps does 23andMe publish?
What kind of apps does 23andMe make?
What is 23andMe's top app?
What fed this analysis
- Apps analyzed:
- 1
- With full intel:
- 1
- With overview:
- 1
- Website scraped:
- yes
- Social presence:
- yes